Tectonic Therapeutic (TECX) Accounts Payables (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Accounts Payables of $2.6 million for Q1 2026, down 59.16% year-over-year from $6.3 million in Q1 2025, and up 133.67% quarter-over-quarter from $1.1 million in Q4 2025.
Tectonic Therapeutic (TECX) Accounts Payables (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Accounts Payables for 10 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 59.16% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 59.16% YoY), while the FY2025 annual figure was $1.1 million, up 11.99% from the prior year.
- Accounts Payables improved to $2.6 million in Q1 2026 per TECX's latest filing, from $1.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.3 million in Q1 2025 and bottomed at $28000.0 in Q2 2022.
- Historically, Accounts Payables has averaged $1.8 million across 5 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables tumbled 98.62% — and 2023, when it soared 3725.0%.
- Tectonic Therapeutic's Accounts Payables stood at $384000.0 in 2022, then increased by 6.51% to $409000.0 in 2023, then soared by 138.63% to $976000.0 in 2024, then grew by 11.99% to $1.1 million in 2025, then soared by 133.67% to $2.6 million in 2026.
- Business Quant data shows TECX's Accounts Payables at $2.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 6.25 Mn |
| Dec 31, 2024 | 976,000.00 |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 243,000.00 |
| Dec 31, 2023 | 409,000.00 |
| Sep 30, 2023 | 910,000.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 2.97 Mn |